John M. Maslowski
Director/Board Member at Alliance for Regenerative Medicine
John M. Maslowski active positions
Companies | Position | Start | End |
---|---|---|---|
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Director/Board Member | 2019-10-01 | - |
Career history of John M. Maslowski
Former positions of John M. Maslowski
Companies | Position | Start | End |
---|---|---|---|
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | Director/Board Member | 2016-11-30 | 2021-04-19 |
Chief Executive Officer | - | 2021-04-19 | |
Chief Operating Officer | 2021-04-19 | 2021-05-30 | |
FIBROCELL SCIENCE, INC. | Comptroller/Controller/Auditor | 2017-06-21 | 2019-08-17 |
Director/Board Member | 2016-12-17 | 2019-12-12 | |
Chief Executive Officer | 2016-12-17 | 2019-12-31 | |
Chief Tech/Sci/R&D Officer | 2005-02-28 | 2016-12-15 | |
Director of Finance/CFO | 2017-06-21 | 2019-08-17 | |
Corporate Officer/Principal | 2005-02-28 | - | |
President | 2016-12-17 | 2019-12-31 | |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Corporate Officer/Principal | 2004-12-31 | 2004-12-31 |
Training of John M. Maslowski
Ursinus College | Undergraduate Degree |
Villanova University | Graduate Degree |
Statistics
International
United States | 7 |
Operational
Director/Board Member | 3 |
Chief Executive Officer | 2 |
Corporate Officer/Principal | 2 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 4 |
---|---|
Fibrocell Science, Inc.
Fibrocell Science, Inc. Pharmaceuticals: MajorHealth Technology Fibrocell Science, Inc. is an autologous cell and gene therapy company, which focuses on translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. The company was founded on December 28, 1995 and is headquartered in Exton, PA. | Health Technology |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Health Technology |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Health Services |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | Health Technology |
- Stock Market
- Insiders
- John M. Maslowski
- Experience